Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression.
Jain SU, Khazaei S, Marchione DM, Lundgren SM, Wang X, Weinberg DN, Deshmukh S, Juretic N, Lu C, Allis CD, Garcia BA, Jabado N, Lewis PW.
Jain SU, et al. Among authors: wang x.
Proc Natl Acad Sci U S A. 2020 Nov 3;117(44):27354-27364. doi: 10.1073/pnas.2006076117. Epub 2020 Oct 16.
Proc Natl Acad Sci U S A. 2020.
PMID: 33067396
Free PMC article.